Itolizumab (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Itolizumab" in English language version.

refsWebsite

Global rank English rank

234^th place

397^th place

987^th place

560^th place

low place

low place

1thehindubusinessline.com

724^th place

431^st place

1web.archive.org

1^st place

1^st place

low place

low place

1indiatimes.com

17^th place

15^th place

biocon.com

"Biocon Receives Marketing Authorization for its Novel Biologic Itolizumab for Psoriasis" (PDF). Biocon Limited. 8 January 2013.

indiatimes.com

economictimes.indiatimes.com

"Biocon's Itolizumab approved for COVID-19 treatment: All you need to know". The Economic Times. Retrieved 2020-07-14.

nature.com

Jayaramun K (December 2013). "Biocon's first-in-class anti-CD6 mAb reaches the market". Nat. Biotechnol. Vol. 31, no. 12. United Kingdom. pp. 1062–3.

pharmabiz.com

"Biocon's psoriasis drug, Itolizumab receives DCGI marketing authorization". Pharmabiz.com. India: Saffron Media. January 8, 2013. Archived from the original on February 19, 2017. Retrieved January 10, 2013.

thehindubusinessline.com

Urs A (10 January 2012). "Biocon's test shows positive results for Itolizumab". @businessline.

theprint.in

"India prepares to test Itolizumab, the drug credited for lowering Covid mortality in Cuba". May 30, 2020.

web.archive.org

"Biocon's psoriasis drug, Itolizumab receives DCGI marketing authorization". Pharmabiz.com. India: Saffron Media. January 8, 2013. Archived from the original on February 19, 2017. Retrieved January 10, 2013.